Assessment of a new treatment schedule in sublingual immunotherapy.: A randomised double-blind placebo-controlled multicentre study

被引：3
|
作者：
Boquete, M
Rodriguez, F
Tabar, A
Ibañez, D
Nieto, A
Torre-Martinez, F
机构：
[1] Hosp Xeral Calde, Lugo, Spain
[2] Hosp Marques Valdecilla, Santander, Spain
[3] Hosp Virgen Del Camino, Pamplona, Spain
[4] Hosp Nino Jesus, Madrid, Spain
[5] Hosp La Fe, Valencia, Spain
[6] ALK ABELLO SA, Madrid, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.646
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
631
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [21] Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen
    Wüthrich, B
    Bucher, C
    Jörg, W
    Bircher, A
    Eng, P
    Schneider, Y
    Schnyder, F
    Eigenmann, P
    Senti, G
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2003, 13 (03) : 145 - 148
  • [22] Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (Dpt) in children
    Hirsch, T
    Sahn, M
    Leupold, W
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 1997, 8 (01) : 21 - 27
  • [23] Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomised, double-blind, placebo-controlled multicentre study
    Flook, N.
    Moayyedi, P.
    Dent, J.
    Talley, N. J.
    Persson, T.
    Karlson, B.
    Ruth, M.
    GUT, 2007, 56 : A42 - A42
  • [24] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    LANCET, 2002, 360 (9350): : 2018 - 2025
  • [25] Prophylactic ibuprofen in premature infants:: a multicentre, randomised, double-blind, placebo-controlled trial
    Van Overmeire, B
    Allegaert, K
    Casaer, A
    Debauche, C
    Decaluwé, W
    Jespers, A
    Weyler, J
    Harrewijn, I
    Langhendries, JP
    LANCET, 2004, 364 (9449): : 1945 - 1949
  • [26] Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study
    Lagreze, Wolf A.
    Kuechlin, Sebastian
    Ihorst, Gabriele
    Grotejohann, Birgit
    Beisse, Flemming
    Volkmann, Martin
    Heinrich, Sven P.
    Albrecht, Philipp
    Ungewiss, Judith
    Woerner, Michael
    Hug, Martin J.
    Wolf, Sebastian
    Diem, Ricarda
    LANCET NEUROLOGY, 2021, 20 (12): : 991 - 1000
  • [27] Effect of hyaluronic acid in symptomatic hip osteoarthritis:: A multicentre, randomised, double-blind, placebo-controlled study
    Richette, Pascal
    Ravaud, Philippe
    Conrozier, Thierry
    Euller-Ziegler, Liana
    Mazieres, Bernard
    Maugars, Yves
    Mulleman, Denis
    Clerson, Pierre
    Chevalier, Xavier
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S485 - S485
  • [28] Therapy of chronic Epicondylopathia humeri radialis with botulinumtoxin A - a double-blind, placebo-controlled and randomised multicentre study
    Placzek, R
    Deuretzbacher, G
    Meiss, LA
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2005, 143 (05): : 498 - 503
  • [29] Effect of chondroitin sulphate in symptomatic knee osteoarthritis:: a multicentre, randomised, double-blind, placebo-controlled study
    Mazieres, Bernard
    Hucher, Michel
    Zaim, Mohammed
    Garnero, Patrick
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (05) : 639 - 645
  • [30] Botulinum toxin A in the prophylactic treatment of migraine - a randomised, double-blind, placebo-controlled study
    Schwaag, S
    Vollmer-Haase, J
    Rahmann, A
    Frese, A
    Husstedt, IW
    Evers, S
    CEPHALALGIA, 2003, 23 (07) : 702 - 702
12345